Our website uses cookies to give you the most optimal experience online by: measuring our audience, understanding how our webpages are viewed and improving consequently the way our website works, providing you with relevant and personalized marketing content.
You have full control over what you want to activate. You can accept the cookies by clicking on the “Accept all cookies” button or customize your choices by selecting the cookies you want to activate. You can also decline all non-necessary cookies by clicking on the “Decline all cookies” button. Please find more information on our use of cookies and how to withdraw at any time your consent on our privacy policy.

Managing your cookies

Our website uses cookies. You have full control over what you want to activate. You can accept the cookies by clicking on the “Accept all cookies” button or customize your choices by selecting the cookies you want to activate. You can also decline all non-necessary cookies by clicking on the “Decline all cookies” button.

Necessary cookies

These are essential for the user navigation and allow to give access to certain functionalities such as secured zones accesses. Without these cookies, it won’t be possible to provide the service.
Matomo on premise

Marketing cookies

These cookies are used to deliver advertisements more relevant for you, limit the number of times you see an advertisement; help measure the effectiveness of the advertising campaign; and understand people’s behavior after they view an advertisement.
Adobe Privacy policy | Marketo Privacy Policy | Pardot Privacy Policy | Oktopost Privacy Policy | MRP Privacy Policy | AccountInsight Privacy Policy | Triblio Privacy Policy

Social media cookies

These cookies are used to measure the effectiveness of social media campaigns.
LinkedIn Policy

Our website uses cookies to give you the most optimal experience online by: measuring our audience, understanding how our webpages are viewed and improving consequently the way our website works, providing you with relevant and personalized marketing content. You can also decline all non-necessary cookies by clicking on the “Decline all cookies” button. Please find more information on our use of cookies and how to withdraw at any time your consent on our privacy policy.

Skip to main content

Life Sciences Center of Excellence | Atos

Located at the Wellcome Genome Campus, home to some of the world’s foremost institutes and organizations in genomics and computational biology, the Atos Life Sciences Center of Excellence brings leading edge technologies closer to research projects with the goal of discovering fresh, innovative solutions that will have a positive impact in society.

For researchers and technologists worldwide, the center is a unique opportunity to explore the power of advanced computing technologies such as high-performance computing, artificial intelligence and quantum simulation.

Processing and analyzing genomics data for the early diagnosis of cancer, biological and chemical process simulation that will shorten the pathway to market of new drugs, implementing computer vision techniques to increase efficiency in healthcare are just a few examples of how this Center of Excellence will bridge the gap between our technologies and our research partners.

Life Sciences R&D professionals : Contact us for more information or to book a visit

Atos Life Sciences Center of Excellence team

The Life Sciences Connect Event marked the premiere of our Life Sciences Center of Excellence in Cambridge.

The event delved into the concept of virtual humans and brought together esteemed speakers from some of the world’s leading research institutions to discuss revolutionary projects in precision health and drug development.

Watch the recording

A unique digital ecosystem to help shape a better world
for individuals and populations

Precision Health

Precision Health

Enable the implementation of a Personalized, Predictive, Preventative, Participatory medicine

Drug Development

Drug Development

From molecule to market: accelerate time to market for new drugs and treatments

Atos’ Life Sciences Center of Excellence

Our vision in Life Sciences is to bridge the gap between research and life sciences. Innovative concepts are brought to life to enable smart, secure, and sustainable health and wellbeing for all through extensive exploration, ongoing discovery, and co-creation by global health and life sciences professionals across Atos & the wider Wellcome Genome Campus ecosystem.

Watch the interview with Natalia Jimenez

Natalia Jimenez, Lead of Atos’ Life Sciences Center of Excellence at Wellcome Genome Campus, talks about how Atos will use the center to provide scientists on campus, and global genome and bio-data institutes, early access to emerging technologies to support their research, accelerate the process of bringing new drugs to market and contribute to a healthier world.

Experience the center in this virtual tour

Atos’ Life Sciences Center for Excellence at the Wellcome Genome Campus in Cambridge is an innovation hub whose ambition is to blend leading-edge technologies with scientific insights to improve people’s lives. This center is designed to complement the existing Campus facilities with technology expertise to provide a unique ecosystem for exploration, discovery and co-creation.

Atos, University College London and Arm join forces to harness the power of cloud and digital for better healthcare

Explore

With data growing exponentially and becoming more difficult to process for life sciences applications, scientists rely on high-performance computing to quickly process and analyse massive amounts of data.

So, Atos, UCL and Arm team up to explore how they can offer wider cloud computing possibilities for life sciences applications.

Discover

The Arm Neoverse-based platform, the Ampere Altra, is dedicated to cloud native workloads, meaning the simulation and the results can be achieved not only on-premises but directly on the cloud, on any type of HPC platforms and from anywhere.

As more and more laboratories are using Arm-based solutions, this project would mean that they will now be able to run applications on their systems, enabling them to easily create workflows that could detect for example mutations in the SARS-CoV-2 genome, in order to ultimately help combat COVID-19.

Co-create

A successful Proof of Concept was co-created. Watch our video exploring this PoC >

This work has combined expertise and skills from Atos and Arm teams focusing on hardware and software optimizations, together with a scientific team from UCL dedicated to define the use cases. This collaboration has enabled the optimization of both software and hardware in this co-design effort to meet the demands of groundbreaking genomics workflows, which are already deployed in clinical settings.

Co-create

A successful Proof of Concept was co-created. Watch our video exploring this PoC below.

This work has combined expertise and skills from Atos and Arm teams focusing on hardware and software optimizations, together with a scientific team from UCL dedicated to define the use cases. This collaboration has enabled the optimization of both software and hardware in this co-design effort to meet the demands of groundbreaking genomics workflows, which are already deployed in clinical settings.

Atos, UCL and Arm join forces to harness the power of cloud and digital for better healthcare

Proof of Concept: Atos and UCL announce having successfully run the virus sequencing tool, Viridian, which is used to detect mutation of the SARS-Cov-2 strain of the coronavirus, using an Arm®-based Ampere® Altra® processor in a cloud-native environment.

Related insights

Accelerating the diagnosis of bowel disease using AI

Millions of people every year suffer from bowel disease. While treatments are advancing, the diagnosis process is still very labor intensive. This video shows how AI technology can help to shorten 8 hour footage significantly, freeing valuable clinician time and accelerating diagnosis for better patient outcomes.

Technological advances to prevent skin cancer

Skin cancer is more common and dangerous than most people think, but treatable when caught early on. This video shows how AI technology can help to classify skin lesions faster and more efficient to accelerate diagnosis and improve patient outcomes.

Leap your life sciences project to the “quantum” level

Listen to Atos’ experts, who will walk you through the fundamentals and applications of quantum computing in life sciences, Atos quantum program and life sciences quantum use cases.

Beating diseases with Artificial Intelligence

Listen to the technologists from three multinational companies- Atos, Nvidia and NetApp, who discuss how AI can help with early disease diagnosis and predict responses of clinical outcomes into medicine. The use of AI to aid diagnose and understand the severity of diseases is becoming imperative for improved patient care.

Virtual Humans

Peter Coveney, Director of the Center for Computational Science at the University of London, talks about how Virtual Humans can shift the focus from reactive to proactive care, help predict disease risks and the evolution of treatments to design personalized treatment regimes.

Contact us

Thank you for your interest. You can download the report here.
A member of our team will be in touch with you shortly

Location

Wellcome Genome Campus
Wellcome Trust Genome Campus,
Saffron Walden CB10 1SA

E-mail us

Talk to our experts

Natalia Jiménez Lozano

Lead of Atos Life Sciences Center of Excellence

Follow or contact Natalia:

Xavier Vigouroux

Co-lead of Atos Life Sciences Center of Excellence

Follow or contact Xavier: